Osteoclast Inhibitors
Dec. 25, 2024
Frontiers | Key Triggers of Osteoclast-Related Diseases and Available Strategies for Targeted Therapies: A Review Frontiers | Finding a Toll on the Route: The Fate of Osteoclast Progenitors After Toll-Like Receptor Activation Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways Osteoclast Inhibitors